Topical Drug Delivery Market by Product Type, Route of Administration - Global Forecast to 2021

  • ID: 4174213
  • Report
  • Region: Global
  • 151 Pages
  • Markets and Markets
1 of 6
Topical Drug Delivery Market worth 125.88 Billion USD by 2021

FEATURED COMPANIES

  • 3M Drug Delivery Systems
  • Bayer AG
  • Cipla
  • Galderma S.A.
  • Glaxosmithkline PLC
  • Medpharm
  • MORE

"Topical Drug Delivery Market by Product Type (Formulation (Solid, Cream, Lotion, Paste, Liquid), Transdermal (Patch, Gel)), Route of Administration (Skin, Ophthalmic, Rectal, Vaginal, Nasal), & Facility of Use (Hospital, Clinic, Home care, Research) - Global Forecast to 2021"

The global topical drug delivery market is poised to reach USD 125.88 billion by 2021 from USD 92.40 billion in 2016, growing at a CAGR of 6.4% from 2016 to 2021. Major factors driving the growth of this market are the high incidence of burn injuries, rising geriatric population, and increasing incidence of diabetes.

The topical drug delivery market is segmented based on product type, route of administration, facility of use, and regions. On the basis of route of administration, the market is segmented into skin, ophthalmic, rectal, vaginal, and nasal routes. Considering the high incidence of skin diseases, high demand for self-administration, and the increasing number of product approvals for skin-related drug delivery systems, the market for topical drugs administered through the skin is expected to register the highest CAGR during the forecast period.

Based on facility of use, the topical drug delivery market is categorized into hospitals and private clinics, health care settings, and other facilities of use such as research institutes and diagnostic centers. The hospitals and private clinics segment is expected to be the major end-user in the topical drug delivery market. This large share of this segment can is mainly attributed to the increasing incidence of skin diseases, the subsequent increase in the demand for topical products for the treatment of these diseases, increase in funding, and infrastructural development in hospitals.

Currently, North America dominates the topical drug delivery market, followed by Europe. However, the market in the Asia-Pacific is expected to witness the highest growth during the forecast period. The high growth in the Asia-Pacific market can be attributed to the rising geriatric population, increasing healthcare expenditure, rising disposable income, and growing focus of global pharmaceutical companies on the markets in emerging APAC countries.

Research Coverage:

This market is categorized on the basis of product type, route of administration, facilities of use, and region. Apart from comprehensive geographical analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players in the last three years. In addition, the company profiles comprise basic views on the key players and their product portfolios, developments, and strategies adopted. The abovementioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of top players in the topical drug delivery market. The report analyzes the topical drug delivery market by product type, route of administration, facilities of use, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the topical drug delivery market.
  • Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the topical drug delivery market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for topical drug delivery across geographies.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the topical drug delivery market.
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • 3M Drug Delivery Systems
  • Bayer AG
  • Cipla
  • Galderma S.A.
  • Glaxosmithkline PLC
  • Medpharm
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Assumptions for the Study

3 Executive Summary

4 Topical Drug Delivery Market: Premium Insights
4.1 Global Market, By Route of Administration
4.2 Global Market, By Product Type
4.3 Global Market, By End User
4.4 Geographic Snapshot of the Global Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.3 Drivers
5.3.1 High Prevalence of Skin Diseases
5.3.2 Growing Preference for Topical Drug Delivery
5.3.3 High Incidence of Burn Injuries
5.3.4 Rising Incidence of Diabetes
5.3.5 Rising Geriatric Population
5.4 Restraints
5.4.1 Negative Impact of Product Recalls
5.5 Opportunities
5.5.1 Delivery of Biologics Through the Transdermal Route
5.5.2 Acquisition of Small Market Players
5.6 Challenges
5.6.1 Limited Therapeutic Areas of Topical Drug Delivery

6 Topical Drug Delivery Market, By Product Type
6.1 Introduction
6.1.1 Formulations
6.1.1.1 Liquid Topical Formulations
6.1.1.1.1 Solutions
6.1.1.1.2 Suspensions
6.1.1.2 Semi-Solid Topical Formulations
6.1.1.2.1 Creams
6.1.1.2.2 Gels
6.1.1.2.3 Ointments
6.1.1.2.4 Pastes
6.1.1.2.5 Lotions
6.1.1.3 Solid Topical Formulations
6.1.1.3.1 Suppositories
6.1.1.3.2 Powders
6.1.2 Devices (Transdermal Drug Delivery)
6.1.2.1 Transdermal Patches
6.1.2.2 Transdermal Gels

7 Topical Drug Delivery Market, By Route of Administration
7.1 Introduction
7.2 Skin Drug Delivery
7.3 Ophthalmic Drug Delivery
7.4 Rectal Drug Delivery
7.5 Vaginal Drug Delivery
7.6 Nasal Drug Delivery

8 Topical Drug Delivery Market, By Facility of Use
8.1 Introduction
8.2 Hospitals and Private Clinics
8.3 Home Care Settings
8.4 Other Facilities of Use

9 Topical Drug Delivery Market, By Region
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Rest of Europe (RoE)
9.4 Asia-Pacific (APAC)
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of Asia-Pacific
9.5 Rest of the World (RoW)

10 Competitive Landscape
10.1 Overview
10.2 Player Ranking
10.3 Competitive Situation and Trends
10.3.1 Product Launches and Approvals
10.3.2 Acquisitions
10.3.3 Agreements & Collaborations
10.3.4 Expansions

11 Company Profiles
(Overview, Products and Services, Financials, Strategy & Development)*
11.1 Glaxosmithkline PLC
11.2 Janssen Global Services, LLC. (A Subsidiary of Johnson & Johnson)
11.3 Novartis AG
11.4 Galderma S.A.
11.5 Valeant Pharmaceuticals International, Inc.
11.6 Bayer AG
11.7 3M Drug Delivery Systems
11.8 Crescita Therapeutics Inc.
11.9 Medpharm
11.10 Cipla

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

12 Appendix
12.1 Insights From Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store
12.4 Other Developments
12.5 Available Customizations
12.6 RT: Real-Time Market Intelligence
12.7 Related Reports
12.8 Author Details

List of Tables:
Table 1 Topical Drug Delivery Market Size, By Product Type, 2014-2021 (USD Billion)
Table 2 Topical Drug Delivery Formulations Market Size, By Type, 2014-2021 (USD Billion)
Table 3 Topical Drug Delivery Formulations Market Size, By Region, 2014-2021 (USD Billion)
Table 4 Liquid Topical Formulations Market Size, By Dosage Form, 2014-2021 (USD Billion)
Table 5 Liquid Topical Formulations Market Size, By Region, 2014-2021 (USD Billion)
Table 6 Topical Solutions Market Size, By Region, 2014-2021 (USD Billion)
Table 7 Topical Suspensions Market Size, By Region, 2014-2021 (USD Billion)
Table 8 Semi-Solid Topical Formulations Market Size, By Dosage Form, 2014-2021 (USD Billion)
Table 9 Semi-Solid Topical Formulations Market Size, By Region, 2014-2021 (USD Billion)
Table 10 Topical Creams Market Size, By Region, 2014-2021 (USD Billion)
Table 11 Topical Gels Market Size, By Region, 2014-2021 (USD Billion)
Table 12 Topical Ointments Market Size, By Region, 2014-2021 (USD Billion)
Table 13 Topical Pastes Market Size, By Region, 2014-2021 (USD Billion)
Table 14 Topical Lotions Market Size, By Region, 2014-2021 (USD Billion)
Table 15 Solid Topical Formulations Market Size, By Dosage Form, 2014-2021 (USD Billion)
Table 16 Solid Topical Formulations Market Size, By Region, 2014-2021 (USD Billion)
Table 17 Topical Suppositories Market Size, By Region, 2014-2021 (USD Billion)
Table 18 Topical Powders Market Size, By Region, 2014-2021 (USD Billion)
Table 19 Transdermal Drug Delivery Devices Market Size, By Type, 2014-2021 (USD Billion)
Table 20 Transdermal Drug Delivery Devices Market Size, By Region, 2014-2021 (USD Billion)
Table 21 Transdermal Patches Market Size, By Region, 2014-2021 (USD Billion)
Table 22 Transdermal Gels Market Size, By Region, 2014-2021 (USD Billion)
Table 23 Topical Drug Delivery Market Size, By Route of Administration, 2014-2021 (USD Billion)
Table 24 Some Commercially Available Products
Table 25 Skin Drug Delivery Market Size, By Region, 2014-2021 (USD Billion)
Table 26 Commercially Available Products
Table 27 Ophthalmic Drug Delivery Market Size, By Region, 2014-2021 (USD Billion)
Table 28 Rectal Drug Delivery Market Size, By Region, 2014-2021 (USD Billion)
Table 29 Vaginal Drug Delivery Market Size, By Region, 2014-2021 (USD Billion)
Table 30 Commercially Available Products
Table 31 Nasal Drug Delivery Market Size, By Region, 2014-2021 (USD Billion)
Table 32 Global Topical Drug Delivery Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 33 Market Size for Hospitals and Private Clinics, By Region, 2014-2021 (USD Billion)
Table 34 Market Size for Home Care Settings, By Region, 2014-2021 (USD Billion)
Table 35 Market Size for Other Facilities of Use, By Region, 2014-2021 (USD Billion)
Table 36 Market Size, By Region, 2014-2021 (USD Billion)
Table 37 North America: Topical Drug Delivery Market Size, By Country, 2014-2021 (USD Billion)
Table 38 North America: Market Size, By Product Type, 2014-2021 (USD Billion)
Table 39 North America: Market Size, By Route of Administration, 2014-2021 (USD Billion)
Table 40 North America: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 41 U.S.: Market Size, By Product Type, 2014-2021 (USD Billion)
Table 42 U.S.: Market Size, By Route of Administration, 2014-2021 (USD Billion)
Table 43 U.S.: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 44 Canada: Topical Drug Delivery Market Size, By Product Type, 2014-2021 (USD Billion)
Table 45 Canada: Market Size, By Route of Administration, 2014-2021 (USD Billion)
Table 46 Canada: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 47 Europe: Market Size, By Country, 2014-2021 (USD Billion)
Table 48 Europe: Market Size, By Product Type, 2014-2021 (USD Billion)
Table 49 Europe: Market Size, By Route of Administration, 2014-2021 (USD Billion)
Table 50 Europe: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 51 Germany: Topical Drug Delivery Market Size, By Product Type, 2014-2021 (USD Billion)
Table 52 Germany: Market Size, By Route of Administration, 2014-2021 (USD Billion)
Table 53 Germany: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 54 France: Market Size, By Product Type, 2014-2021 (USD Billion)
Table 55 France: Market Size, By Route of Administration, 2014-2021 (USD Billion)
Table 56 France: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 57 U.K.: Topical Drug Delivery Market Size, By Product Type, 2014-2021 (USD Billion)
Table 58 U.K.: Market Size, By Route of Administration, 2014-2021 (USD Billion)
Table 59 U.K.: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 60 RoE: Market Size, By Product Type, 2014-2021 (USD Billion)
Table 61 RoE: Market Size, By Route of Administration, 2014-2021 (USD Billion)
Table 62 RoE: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 63 Asia-Pacific: Topical Drug Delivery Market Size, By Country, 2014-2021 (USD Billion)
Table 64 Asia-Pacific: Market Size, By Product Type, 2014-2021 (USD Billion)
Table 65 Asia-Pacific: Market Size, By Route of Administration, 2014-2021 (USD Billion)
Table 66 Asia-Pacific: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 67 Japan.: Market Size, By Product Type, 2014-2021 (USD Billion)
Table 68 Japan: Market Size, By Route of Administration, 2014-2021 (USD Billion)
Table 69 Japan: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 70 China: Topical Drug Delivery Market Size, By Product Type, 2014-2021 (USD Billion)
Table 71 China: Market Size, By Route of Administration, 2014-2021 (USD Billion)
Table 72 China: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 73 India: Market Size, By Product Type, 2014-2021 (USD Billion)
Table 74 India: Market Size, By Route of Administration, 2014-2021 (USD Billion)
Table 75 India: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 76 Rest of Asia-Pacific: Topical Drug Delivery Market Size, By Product Type, 2014-2021 (USD Billion)
Table 77 Rest of Asia-Pacific: Market Size, By Route of Administration, 2014-2021 (USD Billion)
Table 78 Rest of Asia-Pacific: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 79 RoW: Market Size, By Product Type, 2014-2021 (USD Billion)
Table 80 RoW: Market Size, By Route of Administration, 2014-2021 (USD Billion)
Table 81 RoW: Market Size, By Facility of Use, 2014-2021 (USD Billion)
Table 82 Topical Drug Delivery Market, By Key Player, 2015
Table 83 Product Launches & Approvals, 2013-2016
Table 84 Acquisitions, 2013-2017
Table 85 Agreements & Collaborations, 2013-2016
Table 86 Expansions, 2013-2017
Table 87 Exchange Rate (Utilized for Conversion of Inr to USD)

List of Figures:
Figure 1 Research Design
Figure 2 Market Size Estimation: Bottom-Up Approach
Figure 3 Market Size Estimation: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Key Data From Secondary Sources
Figure 7 Key Data From Primary Sources
Figure 8 Formulations Segment is Expected to Dominate the Global Topical Drug Delivery Market, By Product (2016-2021)
Figure 9 Hospitals and Private Clinics Segment is Expected to Hold Largest Share of the Market, By Facility of Use (2016-2021)
Figure 10 Skin Drug Delivery Segment is Expected to Dominate the Topical Drug Delivery Market, By Route of Administration (2016-2021)
Figure 11 North America is Estimated to Hold the Largest Market Share in 2016, While Asia-Pacific is Expected to Witness Highest Growth (2016-2021)
Figure 12 Global Market Overview: Increasing Prevalence of Skin Diseases is Expected to Be the Key Driver of Market Growth
Figure 13 Formulations Segment is Expected to Dominate the Market, By Product
Figure 14 Skin is Estimated to Command the Largest Share of the Route of Administration Market in 2016
Figure 15 Semi-Solid Formulations Segment is Expected to Grow at the Highest CAGR in the Topical Drug Delivery Formulations Market (2016-2021)
Figure 16 Hospitals and Private Clinics Segment is Expected to Witness the Highest CAGR in the Forecast Period
Figure 17 Asia-Pacific is Expected to Grow at the Highest CAGR (2016-2021)
Figure 18 Topical Drug Delivery Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Formulations are Estimated to Command the Larger Share of the Market in 2016
Figure 20 Transdermal Drug Delivery is Expected to Dominate the Market (2016-2021)
Figure 21 Asia-Pacific is Expected to Register the Highest CAGR in the Skin Drug Delivery Market (2016 - 2021)
Figure 22 Hospitals and Private Clinics Segment is Estimated to Command the Largest Share of the Global Market in 2016
Figure 23 Asia-Pacific Hospitals and Private Clinics Market is Expected to Witness Highest CAGR (2016 - 2021)
Figure 24 North America: Topical Drug Delivery Market Snapshot
Figure 25 Europe: Market Snapshot
Figure 26 Asia-Pacific: Market Snapshot
Figure 27 RoW: Market Snapshot
Figure 28 Key Developments in the Global Market, 2013-2017
Figure 29 Market Evolution Framework
Figure 30 Battle for Market Share: Product Launches and Approvals Accounted for the Largest Share of Strategies (2013-2016)
Figure 31 Geographic Revenue Mix of the Top Five Players in the Topical Drug Delivery Market, 2015
Figure 32 Glaxosmithkline PLC: Company Snapshot (2015)
Figure 33 Johnson & Johnson: Company Snapshot (2015)
Figure 34 Novartis AG: Company Snapshot (2015)
Figure 35 Nestlé S.A.: Company Snapshot (2015)
Figure 36 Valeant Pharmaceuticals International, Inc.: Company Snapshot (2015)
Figure 37 Bayer AG: Company Snapshot (2015)
Figure 38 Exchange Rate (Utilized for the Conversion of EUR to USD)
Figure 39 3M: Company Snapshot (2015)
Figure 40 Nuvo Research: Company Snapshot (2015)
Figure 41 Cipla: Company Snapshot (2015)

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • 3M Drug Delivery Systems
  • Bayer AG
  • Cipla
  • Crescita Therapeutics Inc.
  • Galderma S.A.
  • Glaxosmithkline PLC
  • Janssen Global Services, LLC. (A Subsidiary of Johnson & Johnson)
  • Medpharm
  • Novartis AG
  • Valeant Pharmaceuticals International, Inc.
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll